Ind-Swift Laboratories Stock Scales New 52-Week Peak at Rs 419: Key Reasons Behind the Surge
- September 24, 2026
- Posted by: Harsh Piplani
- Category: News
Ind-Swift Laboratories Share Price was at Rs 408.9 in early trade on 24 September 2026, up Rs 3.85 or 0.95% from the previous close of Rs 405.05. The stock touched a fresh 52-week high of Rs 419.05 during the session and closed the visible price update with market capitalisation of Rs 3,529.77 crore. In a 52-week high event, the key takeaway is the verified price move itself: the stock has printed a yearly high, and the available data confirms the level reached today.
This Ind-Swift Laboratories Share Price Today update is relevant because it combines the day’s move, the session high, the opening price of Rs 404 and the low of Rs 400 with turnover of Rs 1.03 crore. The price event is real and measurable, while the supplied data does not establish a company-specific catalyst. For readers following Ind-Swift Laboratories Stock News or Ind-Swift Laboratories Share Price News, the session now sits at the centre of market attention on a factual basis. Univest is tracking the move, the valuation metrics and the wider healthcare context in this stock analysis.
Ind-Swift Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 408.9 |
| Previous Close | Rs 405.05 |
| Today's Move | +Rs 3.85 (+0.95%) |
| Open | Rs 404 |
| High | Rs 419.05 |
| Low | Rs 400 |
| Turnover | Rs 1.03 crore |
| Market Capitalisation | Rs 3,529.77 crore |
Ind-Swift Laboratories Ltd. (INDSWFTLAB) traded at Rs 408.9 versus the previous close of Rs 405.05, a rise of 0.95%. The stock opened at Rs 404, reached a high of Rs 419.05 and touched a low of Rs 400.
Ind-Swift Laboratories Share Price opened at Rs 404, moved between Rs 400 and Rs 419.05, and was last recorded at Rs 408.9 against the previous close of Rs 405.05. That places the stock Rs 3.85 higher for the day, or 0.95%, while also marking a fresh 52-week high at Rs 419.05. The session shows a clear upward extension from the opening level to the high, and the closing level remained close to the upper part of the day’s band. Turnover stood at Rs 1.03 crore, which is a factual traded-value measure and should be read alongside the price move rather than as a separate signal. For anyone following Ind-Swift Laboratories Share Price Live or Ind-Swift Laboratories Share Price Update, today’s move is straightforward: the stock printed a one-year high and held above the previous close at the latest update. That sets up the next question around the financial context behind the Ind-Swift Laboratories Share Price move.
Ind-Swift Laboratories Ltd. (INDSWFTLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 3,529.77 crore |
| P/E Ratio | 61.45x |
| P/B Ratio | 2.5x |
| ROE | 3.47% |
| ROCE | 4% |
| EPS | Rs 6.59 |
| Book Value Per Share | Rs 161.89 |
| Dividend Yield | 0% |
Ind-Swift Laboratories Ltd. (INDSWFTLAB) fundamental metrics show P/E 61.45x, P/B 2.5x, ROE 3.47%, ROCE 4%. These figures provide context only and are not a buy or sell signal.
Ind-Swift Laboratories Ltd. has a market capitalisation of Rs 3529.77 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 61.45x, P/B at 2.5x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 3.47% and ROCE of 4%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 6.59, book value per share of Rs 161.89, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.89x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 61.45x |
| Benchmark Median P/E | 31.89x |
| Benchmark Average P/E | 49.94x |
| Benchmark P/E Range | 3.48x to 762.66x |
| Company P/B Ratio | 2.5x |
| Benchmark Median P/B | 3.04x |
| Company ROE | 3.47% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 4% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 3,529.77 crore |
| Benchmark Median Market Cap | Rs 745.38 crore |
Ind-Swift Laboratories Ltd. (INDSWFTLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a P/E ratio of 61.45x, which is above the benchmark median of 31.89x, a difference of +92.69%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a ROE of 3.47%, which is below the benchmark median of 11.7%, a difference of -70.34%. Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a ROCE of 4%, which is below the benchmark median of 13.61%, a difference of -70.61%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Advanced Enzyme Technologies Ltd. | ADVENZYMES | 3,324.01 | 20.05 | 2 | 11.43 | 15.27 |
| Unichem Laboratories Ltd. | UNICHEMLAB | 3,764.24 | 13.24 | 1.47 | 9.81 | 10.68 |
| Aarti Drugs Ltd. | AARTIDRUGS | 3,888.1 | 20.83 | 2.49 | 13.36 | 12.04 |
| Kwality Pharmaceuticals Ltd. | KPL | 3,893.25 | 47.69 | 10.84 | 22.67 | 24.01 |
| Gufic Biosciences Ltd. | GUFICBIO | 4,433.49 | 59.65 | 6.38 | 10.14 | 12.56 |
Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a P/E ratio of 61.45x compared with the displayed peer median of 20.83x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 3.47% compares with a peer median of 11.43% across the companies shown in the table. ROCE stood at 4% versus the displayed peer median of 12.56%, providing a capital-efficiency comparison. Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a market capitalisation of Rs 3,529.77 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Ind-Swift Laboratories
- Ind-Swift Laboratories Share Price touched a fresh 52-week high of Rs 419.05 and was last recorded at Rs 408.9.
- The day’s move was Rs 3.85, or 0.95%, versus the previous close of Rs 405.05.
- Market capitalisation stood at Rs 3,529.77 crore at the time of the update.
- P/E is 61.45, EPS is Rs 6.59 and book value is Rs 161.89 per share.
- ROE at 3.47% and ROCE at 4% sit below the supplied industry medians.
About Ind-Swift Laboratories
Ind-Swift Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company profile identifies the business through its listed market identity as Ind-Swift Laboratories Ltd. (INDSWFTLAB), with market data available on NSE and BSE. In this article, Univest is using only the verified financial and classification data supplied in the workflow to keep the company overview factual and concise. The current share price event, valuation context and sector placement are the main items relevant to today’s Ind-Swift Laboratories Stock News.
Track Ind-Swift Laboratories Share Price on Univest
Use Ind-Swift Laboratories Ltd. (INDSWFTLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Ind-Swift Laboratories Share Price on Univest for live price updates, 52-week levels, key valuation ratios, shareholding pattern, sector context and stock analysis. Univest also brings together the share price, market cap, fundamental data and peer comparisons in one place for faster review.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Ind-Swift Laboratories Share Price today?
Ans. Ind-Swift Laboratories Share Price was Rs 408.9 at the latest update, up Rs 3.85 or 0.95% from the previous close of Rs 405.05. The stock also touched Rs 419.05 during the session.
Did Ind-Swift Laboratories hit a fresh 52-week high?
Ans. Yes. Ind-Swift Laboratories hit a fresh 52-week high of Rs 419.05 in the session. That makes today’s update a one-year high event, not an all-time high claim, based on the supplied data.
What does the Ind-Swift Laboratories Share Price move show?
Ans. The stock moved from an open of Rs 404 to a high of Rs 419.05 and was last recorded at Rs 408.9. The data confirms the price event, but not any company-specific catalyst.
How is Ind-Swift Laboratories valued on P/E and P/B?
Ans. Ind-Swift Laboratories has a P/E ratio of 61.45 and a P/B ratio of 2.5. In the supplied industry benchmark, P/E is above the median and P/B is below the median.
What do ROE and ROCE say about Ind-Swift Laboratories?
Ans. ROE is 3.47% and ROCE is 4% for Ind-Swift Laboratories. Both are below the supplied industry medians, so they give useful context for Fundamental Analysis alongside EPS and book value.
Which sector and industry does Ind-Swift Laboratories belong to?
Ans. Ind-Swift Laboratories is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied benchmark covers 199 same-industry companies and 286 companies in the same sector. The stock belongs to the Healthcare sector.
